Magnetic/Acoustic Dual‐Controlled Microrobot Overcoming Oto‐Biological Barrier for On‐Demand Multidrug Delivery against Hearing Loss
Small · 2024
DOI: 10.1002/smll.202401369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Xinyang Yi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Advanced Drug Delivery & Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Cent…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Hearing Loss. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Guangdong-Macao Science and Technology Innovation Joint Project, Guangzhou Basic and Applied Basic Research Project.
Abstract (Originalsprache)
Multidrug combination therapy in the inner ear faces diverse challenges due to the distinct physicochemical properties of drugs and the difficulties of overcoming the oto‐biologic barrier. Although nanomedicine platforms offer potential solutions to multidrug delivery, the access of drugs to the inner ear remains limited. Micro/nanomachines, capable of delivering cargo actively, are promising tools for overcoming bio‐barriers. Herein, a novel microrobot‐based strategy to penetrate the round window membrane (RWM) is presented and multidrug in on‐demand manner is delivered. The tube‐type microrobot (TTMR) is constructed using the template‐assisted layer‐by‐layer (LbL) assembly of chitosan/ferroferric oxide/silicon dioxide (CS/Fe 3 O 4 /SiO 2 ) and loaded with anti‐ototoxic drugs (curcumin, CUR and tanshinone IIA, TSA) and perfluorohexane (PFH). Fe 3 O 4 provides magnetic actuation, while PFH ensures acoustic propulsion. Upon ultrasound stimulation, the vaporization of PFH enables a microshotgun‐like behavior, propelling the drugs through barriers and driving them into the inner ear. Notably, the proportion of drugs entering the inner ear can be precisely controlled by varying the feeding ratios. Furthermore, in vivo studies demonstrate that the drug‐loaded microrobot exhibits superior protective effects and excellent biosafety toward cisplatin (CDDP)‐induced hearing loss. Overall, the microrobot‐based strategy provides a promising direction for on‐demand multidrug delivery for ear diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Advanced Drug Delivery & Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Center for Drug Research and Development, Guangdong Pharmaceutical Univers…
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, P. R. China.
- Guangdong Sunho Pharmaceutical Co. Ltd, Zhongshan, 528437, P. R. China.
ORCID-Profile: Gang Chen
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Guangdong-Macao Science and Technology Innovation Joint Project
- Guangzhou Basic and Applied Basic Research Project
- Innovation Project of Guangdong Graduate Education
- "Climbing Program" Special Funds of Guangdong Province
- National Natural Science Foundation of China
- Guangzhou Key Research and Development Program
Zitieren
APA
Yi, X., Guo, L., Zeng, Q., Huang, S., Wen, D., Wang, C., Kou, Y., Zhang, M., Li, H., Wen, L., & Chen, G. (2024). Magnetic/Acoustic Dual‐Controlled Microrobot Overcoming Oto‐Biological Barrier for On‐Demand Multidrug Delivery against Hearing Loss. Small. https://doi.org/10.1002/smll.202401369
Vancouver
Yi X, Guo L, Zeng Q, Huang S, Wen D, Wang C, et al. Magnetic/Acoustic Dual‐Controlled Microrobot Overcoming Oto‐Biological Barrier for On‐Demand Multidrug Delivery against Hearing Loss. Small. 2024. doi:10.1002/smll.202401369
BibTeX
@article{Yi2024,
author = {Yi, Xinyang and Guo, Lifang and Zeng, Qi and Huang, Suling and Wen, Dingsheng and Wang, Chu and Kou, Yuwei and Zhang, Ming and Li, Huaan and Wen, Lu and Chen, Gang},
title = {Magnetic/Acoustic Dual‐Controlled Microrobot Overcoming Oto‐Biological Barrier for On‐Demand Multidrug Delivery against Hearing Loss},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202401369}
}
EUVIMED